[HTML][HTML] Mutated clones driving leukemic transformation are already detectable at the single-cell level in CD34-positive cells in the chronic phase of primary …
S Parenti, S Rontauroli, C Carretta, S Mallia… - NPJ Precision …, 2021 - nature.com
Disease progression of myeloproliferative neoplasms is the result of increased genomic
complexity. Since the ability to predict disease evolution is crucial for clinical decisions, we …
complexity. Since the ability to predict disease evolution is crucial for clinical decisions, we …
[PDF][PDF] Mutated clones driving leukemic transformation are already detectable at the single cell level in CD34-positive cells in the chronic phase of primary …
S Parenti, S Rontauroli, C Carretta, S Mallia… - scholar.archive.org
Disease progression of myeloproliferative neoplasms is the result of increased genomic
complexity. Since the ability to predict disease evolution is crucial for clinical decision, we …
complexity. Since the ability to predict disease evolution is crucial for clinical decision, we …
Mutated clones driving leukemic transformation are already detectable at the single-cell level in CD34-positive cells in the chronic phase of primary myelofibrosis
S Parenti, S Rontauroli, C Carretta, S Mallia… - NPJ PRECISION …, 2021 - iris.hunimed.eu
Disease progression of myeloproliferative neoplasms is the result of increased genomic
complexity. Since the ability to predict disease evolution is crucial for clinical decisions, we …
complexity. Since the ability to predict disease evolution is crucial for clinical decisions, we …
Mutated clones driving leukemic transformation are already detectable at the single-cell level in CD34-positive cells in the chronic phase of primary myelofibrosis
S Parenti, S Rontauroli, C Carretta, S Mallia… - NPJ PRECISION …, 2021 - iris.unimore.it
Disease progression of myeloproliferative neoplasms is the result of increased genomic
complexity. Since the ability to predict disease evolution is crucial for clinical decisions, we …
complexity. Since the ability to predict disease evolution is crucial for clinical decisions, we …
[PDF][PDF] Mutated clones driving leukemic transformation are already detectable at the single cell level in CD34-positive cells in the chronic phase of primary …
S Parenti, S Rontauroli, C Carretta, S Mallia… - researchgate.net
Disease progression of myeloproliferative neoplasms is the result of increased genomic
complexity. Since the ability to predict disease evolution is crucial for clinical decision, we …
complexity. Since the ability to predict disease evolution is crucial for clinical decision, we …
Mutated clones driving leukemic transformation are already detectable at the single-cell level in CD34-positive cells in the chronic phase of primary myelofibrosis
S Parenti, R Sebastiano, C Chiara… - NPJ Precision …, 2021 - search.proquest.com
Disease progression of myeloproliferative neoplasms is the result of increased genomic
complexity. Since the ability to predict disease evolution is crucial for clinical decisions, we …
complexity. Since the ability to predict disease evolution is crucial for clinical decisions, we …
Mutated clones driving leukemic transformation are already detectable at the single cell level in CD34-positive cells in the chronic phase of primary myelofibrosis
S Parenti, S Rontauroli, C Carretta, S Mallia… - bioRxiv, 2020 - biorxiv.org
Disease progression of myeloproliferative neoplasms is the result of increased genomic
complexity. Since the ability to predict disease evolution is crucial for clinical decision, we …
complexity. Since the ability to predict disease evolution is crucial for clinical decision, we …
Mutated clones driving leukemic transformation are already detectable at the single-cell level in CD34-positive cells in the chronic phase of primary myelofibrosis.
S Parenti, S Rontauroli, C Carretta, S Mallia… - NPJ Precision …, 2021 - europepmc.org
Disease progression of myeloproliferative neoplasms is the result of increased genomic
complexity. Since the ability to predict disease evolution is crucial for clinical decisions, we …
complexity. Since the ability to predict disease evolution is crucial for clinical decisions, we …
Mutated clones driving leukemic transformation are already detectable at the single-cell level in CD34-positive cells in the chronic phase of primary myelofibrosis
S Parenti, S Rontauroli, C Carretta… - NPJ precision …, 2021 - pubmed.ncbi.nlm.nih.gov
Disease progression of myeloproliferative neoplasms is the result of increased genomic
complexity. Since the ability to predict disease evolution is crucial for clinical decisions, we …
complexity. Since the ability to predict disease evolution is crucial for clinical decisions, we …
Mutated clones driving leukemic transformation are already detectable at the single-cell level in CD34-positive cells in the chronic phase of primary myelofibrosis
C Carretta - communities.springernature.com
Single cell analysis has recently emerged as a novel technique able to deepen the
knowledge of the molecular pathogenesis of cancer. Primary Myelofibrosis (PMF) is an …
knowledge of the molecular pathogenesis of cancer. Primary Myelofibrosis (PMF) is an …